SCHEMBL17621836

SCHEMBL17621836

COc1cc(Cl)c(CC(F)(F)F)cc1NCC(=O)N1CCN(C2CNC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.41
▸ KRAS P01116 3/20 0.41
▸ SHMT2 P34897 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.35
▸ SCD O00767 1/20 0.35
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ CCR1 P32246 1/20 0.34
▸ CHEK1 O14757 1/20 0.33
▸ STAT3 P40763 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ F10 P00742 1/20 0.33
▸ RAB9A P51151 1/20 0.33
▸ ADAMTS5 Q9UNA0 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17643345 0.87 KRAS (0.52) GAAKRASSHMT2ALDH1A1SCD
SCHEMBL16122668 0.86 KRAS (0.60) GAAKRASSHMT2
SCHEMBL16122573 0.85 KRAS (0.46) GAAKRASSHMT2ALDH1A1SCD
SCHEMBL16122675 0.85 KRAS (0.44) GAAKRASSHMT2
SCHEMBL21302146 0.83 KRAS (0.46) GAAKRASSHMT2MEN1KMT2A
SCHEMBL16129117 0.76 SMN1; SMN2 (0.39) ALDH1A1CYP3A4CYP2C19MEN1KMT2A
SCHEMBL16102313 0.75 KRAS (0.46) GAAKRASSHMT2CYP3A4CYP2C19
SCHEMBL20260100 0.75 KRAS (0.55) KRASALDH1A1MEN1KMT2A
SCHEMBL16122893 0.75 KRAS (0.65) GAAKRASSHMT2CYP3A4CYP2C19
SCHEMBL17643505 0.73 KRAS (0.69) GAAKRASSCD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016044772-A1 COMBINATION THERAPIES FOR TREATMENT OF CANCER ARAXES PHARMA LLC (US) 2016-03-24 — — WO disclosed
Send feedback